KSS vs REGN · P/E 6.5, rev $6.68B vs P/E 14, rev $4.29B
Kohl's Corporation (KSS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Kohl's Corporation (KSS) is a department stores company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported KSS revenue for 2026-08-01 was $6.68B. Net income was $137.0M. KSS currently screens at market cap $1.74B and trailing P/E 6.5.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
KSS currently screens at market cap $1.74B and trailing P/E 6.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the KSS and REGN stock pages for the full models.
Not investment advice.